Oligomeric amyloid-β targeted contrast agent for MRI evaluation of Alzheimer’s disease mouse models
Article in Frontiers in Pharmacology (June 2024)
The most recent citing publications are shown below. View all 52 publications that cite this research output on Dimensions.
Article in Frontiers in Pharmacology (June 2024)
Article in Neuropharmacology (May 2024)
Article in PLOS ONE (March 2024)